Clicky

Inventiva S.A.(IVA)

Description: Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.


Keywords: Biology Alcohol Hepatitis Genetics Gene Expression Fibrosis Steatohepatitis Non Alcoholic Fatty Liver Disease Transcription DNA Small Molecule Therapies Transcription Factors Receptor Transcription Factor Epigenetics Hepatitis A

Home Page: www.inventivapharma.com

IVA Technical Analysis

50 rue de Dijon
Daix, 21121
France
Phone: 33 3 80 44 75 00


Officers

Name Title
Mr. Frederic Cren Co-Founder, CEO & Chairman
Dr. Pierre Broqua Ph.D. Co-Founder, Chief Scientific Officer, Deputy CEO & Director
Mr. Jean Volatier Chief Financial Officer
Mr. Eric Duranson L.L.M. Gen. Counsel
Ms. Nathalie Harroy Head of HR
Dr. Irena Konstantinova Head of Biology & Pharmacology
Dr. Michael Cooreman Chief Medical Officer
Mr. Jean-Paul Dutertre M.D. Head of Pharmacovigilance

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.299
Price-to-Sales TTM: 19.1815
IPO Date: 2020-07-10
Fiscal Year End: December
Full Time Employees: 109
Back to stocks